Literature DB >> 33791448

Detecting Mild Cognitive Impairment via Digital Biomarkers of Cognitive Performance Found in Klondike Solitaire: A Machine-Learning Study.

Karsten Gielis1, Marie-Elena Vanden Abeele2, Katrien Verbert3, Jos Tournoy4,5, Maarten De Vos6, Vero Vanden Abeele1.   

Abstract

BACKGROUND: Mild cognitive impairment (MCI) is a condition that entails a slight yet noticeable decline in cognition that exceeds normal age-related changes. Older adults living with MCI have a higher chance of progressing to dementia, which warrants regular cognitive follow-up at memory clinics. However, due to time and resource constraints, this follow-up is conducted at separate moments in time with large intervals in between. Casual games, embedded into the daily life of older adults, may prove to be a less resource-intensive medium that yields continuous and rich data on a patient's cognition.
OBJECTIVE: To explore whether digital biomarkers of cognitive performance, found in the casual card game Klondike Solitaire, can be used to train machine-learning models to discern games played by older adults living with MCI from their healthy counterparts.
METHODS: Digital biomarkers of cognitive performance were captured from 23 healthy older adults and 23 older adults living with MCI, each playing 3 games of Solitaire with 3 different deck shuffles. These 3 deck shuffles were identical for each participant. Using a supervised stratified, 5-fold, cross-validated, machine-learning procedure, 19 different models were trained and optimized for F1 score.
RESULTS: The 3 best performing models, an Extra Trees model, a Gradient Boosting model, and a Nu-Support Vector Model, had a cross-validated F1 training score on the validation set of ≥0.792. The F1 score and AUC of the test set were, respectively, >0.811 and >0.877 for each of these models. These results indicate psychometric properties comparative to common cognitive screening tests.
CONCLUSION: The results suggest that commercial card games, not developed to address specific mental processes, may be used for measuring cognition. The digital biomarkers derived from Klondike Solitaire show promise and may prove useful to fill the current blind spot between consultations.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Cognitive monitoring; Dementia; Digital biomarkers; Klondike Solitaire; Machine learning; Mild cognitive impairment

Year:  2021        PMID: 33791448      PMCID: PMC7991273          DOI: 10.1159/000514105

Source DB:  PubMed          Journal:  Digit Biomark        ISSN: 2504-110X


  21 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 3.  Trends on the application of serious games to neuropsychological evaluation: A scoping review.

Authors:  Sonia Valladares-Rodríguez; Roberto Pérez-Rodríguez; Luis Anido-Rifón; Manuel Fernández-Iglesias
Journal:  J Biomed Inform       Date:  2016-11-01       Impact factor: 6.317

4.  Risk of dementia after fluctuating mild cognitive impairment: when the yo-yoing stops.

Authors:  Alan B Zonderman; Gregory A Dore
Journal:  Neurology       Date:  2013-12-18       Impact factor: 9.910

5.  Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Authors:  Ronald C Petersen; Oscar Lopez; Melissa J Armstrong; Thomas S D Getchius; Mary Ganguli; David Gloss; Gary S Gronseth; Daniel Marson; Tamara Pringsheim; Gregory S Day; Mark Sager; James Stevens; Alexander Rae-Grant
Journal:  Neurology       Date:  2017-12-27       Impact factor: 9.910

6.  Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?

Authors:  Tiago C C Pinto; Leonardo Machado; Tatiana M Bulgacov; Antônio L Rodrigues-Júnior; Maria L G Costa; Rosana C C Ximenes; Everton B Sougey
Journal:  Int Psychogeriatr       Date:  2018-11-14       Impact factor: 3.878

7.  Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

Authors:  J C Morris
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

Review 8.  The First Frontier: Digital Biomarkers for Neurodegenerative Disorders.

Authors:  E Ray Dorsey; Spyros Papapetropoulos; Mulin Xiong; Karl Kieburtz
Journal:  Digit Biomark       Date:  2017-07-04

Review 9.  Mild Cognitive Impairment in Geriatrics.

Authors:  Eric G Tangalos; Ronald C Petersen
Journal:  Clin Geriatr Med       Date:  2018-08-21       Impact factor: 3.076

10.  Current State of Digital Biomarker Technologies for Real-Life, Home-Based Monitoring of Cognitive Function for Mild Cognitive Impairment to Mild Alzheimer Disease and Implications for Clinical Care: Systematic Review.

Authors:  Antoine Piau; Katherine Wild; Nora Mattek; Jeffrey Kaye
Journal:  J Med Internet Res       Date:  2019-08-30       Impact factor: 5.428

View more
  2 in total

Review 1.  Digital Cognitive Biomarker for Mild Cognitive Impairments and Dementia: A Systematic Review.

Authors:  Zihan Ding; Tsz-Lok Lee; Agnes S Chan
Journal:  J Clin Med       Date:  2022-07-19       Impact factor: 4.964

2.  Digital Biomarkers for Well-being Through Exergame Interactions: Exploratory Study.

Authors:  Despoina Petsani; Evdokimos Konstantinidis; Aikaterini-Marina Katsouli; Vasiliki Zilidou; Sofia B Dias; Leontios Hadjileontiadis; Panagiotis Bamidis
Journal:  JMIR Serious Games       Date:  2022-09-13       Impact factor: 3.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.